DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Yuqing Wu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Branch of National Clinical Re…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Signal Transduction, B-Lymphocytes, Dopamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Branch of National Clinical Research Center for Laboratory Medicine, Nanjing 210029, China.
- Jiangsu Breast Disease Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210036, China; Department of Breast Surgery, Women's Hospital of Nanjing Medical University (Nanjing Women and Children…
- Department of Clinical Laboratory, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
- Department of Immunology, Nanjing Medical University, Nanjing 211166, China.
- Department of Medical Laboratory, Affiliated Children's Hospital of Jiangnan University, Wuxi 214000, China.
- The First Clinical School of Nanjing Medical University, Nanjing 210029, China.
Förderung
- Fundamental Research Funds for the Central Universities
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Nanjing Medical University
- Soochow University
Zitieren
APA
Wu, Y., Zhu, L., Li, S., Liu, L., Wang, Y., Yang, Y., Mu, Y., Zhu, Q., Jiang, Y., Wu, C., Xi, P., Ma, C., Liang, L., Gao, M., Hu, Y., Ding, Q., & Pan, S. (2025). DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115364
Vancouver
Wu Y, Zhu L, Li S, Liu L, Wang Y, Yang Y, et al. DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115364
BibTeX
@article{Wu2025,
author = {Wu, Yuqing and Zhu, Lei and Li, Sheng and Liu, Lu and Wang, Yaman and Yang, Yongbing and Mu, Yuan and Zhu, Qiuying and Jiang, Yuying and Wu, Chunyan and Xi, Peiwen and Ma, Chunmei and Liang, Lijun and Gao, Min and Hu, Yingchao and Ding, Qiang and Pan, Shiyang},
title = {DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115364}
}
EUVIMED